Updated version of the Burkholderia cepacia complex experimental strain panel.
作者信息
Coenye Tom, Vandamme Peter, LiPuma John J, Govan John R W, Mahenthiralingam Eshwar
出版信息
J Clin Microbiol. 2003 Jun;41(6):2797-8. doi: 10.1128/JCM.41.6.2797-2798.2003.
Abstract
摘要
相似文献
1
Updated version of the Burkholderia cepacia complex experimental strain panel.
J Clin Microbiol. 2003 Jun;41(6):2797-8. doi: 10.1128/JCM.41.6.2797-2798.2003.
2
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.
J Clin Microbiol. 2000 Feb;38(2):910-3. doi: 10.1128/JCM.38.2.910-913.2000.
3
Nosocomial Acquisition of Burkholderia gladioli in patients with cystic fibrosis.
Am J Respir Crit Care Med. 1999 Jul;160(1):374-5. doi: 10.1164/ajrccm.160.1.16011.
4
Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
Clin Infect Dis. 2001 Nov 1;33(9):1469-75. doi: 10.1086/322684. Epub 2001 Oct 4.
5
Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools.
FEMS Immunol Med Microbiol. 2002 Jun 3;33(2):143-9. doi: 10.1111/j.1574-695X.2002.tb00584.x.
6
Genomovar distribution of the Burkholderia cepacia complex differs significantly between Czech and Slovak patients with cystic fibrosis.
J Med Microbiol. 2003 Jul;52(Pt 7):603-604. doi: 10.1099/jmm.0.05163-0.
7
Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.
Int J Syst Evol Microbiol. 2001 Jul;51(Pt 4):1481-1490. doi: 10.1099/00207713-51-4-1481.
8
Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center.
J Clin Microbiol. 2000 Apr;38(4):1651-5. doi: 10.1128/JCM.38.4.1651-1655.2000.
9
Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.
J Clin Microbiol. 1999 Jul;37(7):2158-64. doi: 10.1128/JCM.37.7.2158-2164.1999.
10
Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.
J Clin Microbiol. 1997 Mar;35(3):614-9. doi: 10.1128/jcm.35.3.614-619.1997.
引用本文的文献
1
Bismuth drug eradicates multi-drug resistant complex aerobic respiration.
Chem Sci. 2025 May 9. doi: 10.1039/d5sc02049b.
2
A flagella-dependent jumbo phage controls rice seedling rot and steers toward reduced virulence in rice seedlings.
mBio. 2025 Mar 12;16(3):e0281424. doi: 10.1128/mbio.02814-24. Epub 2025 Jan 27.
3
Identification of Burkholderia cepacia Complex: Comparing Conventional, Automated, and Molecular Methods in a Tertiary Care Center.
Cureus. 2024 Oct 4;16(10):e70847. doi: 10.7759/cureus.70847. eCollection 2024 Oct.
4
Genomic analyses of respiratory isolates indicates two evolutionarily distinct clades.
Front Microbiol. 2023 Nov 21;14:1274280. doi: 10.3389/fmicb.2023.1274280. eCollection 2023.
5
The Isolation and Characterization of a Broad Host Range Bcep22-like Podovirus JC1.
Viruses. 2022 Apr 29;14(5):938. doi: 10.3390/v14050938.
6
Evaluation of Three Culture Media for Isolation of Complex from Respiratory Samples of Patients with Cystic Fibrosis.
Microorganisms. 2021 Dec 16;9(12):2604. doi: 10.3390/microorganisms9122604.
7
A Histone-Like Nucleoid Structuring Protein Regulates Several Virulence Traits in Burkholderia multivorans.
Appl Environ Microbiol. 2021 Jun 25;87(14):e0036921. doi: 10.1128/AEM.00369-21.
8
Regulator LdhR and d-Lactate Dehydrogenase LdhA of Burkholderia multivorans Play Roles in Carbon Overflow and in Planktonic Cellular Aggregate Formation.
Appl Environ Microbiol. 2017 Sep 15;83(19). doi: 10.1128/AEM.01343-17. Print 2017 Oct 1.
9
Cyanide Toxicity to Burkholderia cenocepacia Is Modulated by Polymicrobial Communities and Environmental Factors.
Front Microbiol. 2016 May 18;7:725. doi: 10.3389/fmicb.2016.00725. eCollection 2016.
10
Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.
J Clin Microbiol. 2016 Jul;54(7):1797-1803. doi: 10.1128/JCM.00471-16. Epub 2016 Apr 20.
本文引用的文献
1
Burkholderia cenocepacia sp. nov.--a new twist to an old story.
Res Microbiol. 2003 Mar;154(2):91-6. doi: 10.1016/S0923-2508(03)00026-3.
2
Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III.
J Clin Microbiol. 2002 Sep;40(9):3300-7. doi: 10.1128/JCM.40.9.3300-3307.2002.
3
Burkholderia cepacia complex infection in patients with cystic fibrosis.
J Med Microbiol. 2002 Jul;51(7):533-538. doi: 10.1099/0022-1317-51-7-533.
4
Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools.
FEMS Immunol Med Microbiol. 2002 Jun 3;33(2):143-9. doi: 10.1111/j.1574-695X.2002.tb00584.x.
5
Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains.
Annu Rev Phytopathol. 2001;39:225-58. doi: 10.1146/annurev.phyto.39.1.225.
6
Taxonomy and identification of the Burkholderia cepacia complex.
J Clin Microbiol. 2001 Oct;39(10):3427-36. doi: 10.1128/JCM.39.10.3427-3436.2001.
7
Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas.
Eur Respir J. 2001 Feb;17(2):295-301. doi: 10.1183/09031936.01.17202950.
8
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.
J Clin Microbiol. 2000 Feb;38(2):910-3. doi: 10.1128/JCM.38.2.910-913.2000.
9
Burkholderia cepacia. Management issues and new insights.
Clin Chest Med. 1998 Sep;19(3):473-86, vi. doi: 10.1016/s0272-5231(05)70094-0.
10
Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?
Emerg Infect Dis. 1998 Apr-Jun;4(2):221-7. doi: 10.3201/eid0402.980209.
Zotero 插件